ABUS
Price
$4.41
Change
+$0.09 (+2.08%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
845.39M
39 days until earnings call
ROIV
Price
$15.17
Change
+$0.21 (+1.40%)
Updated
Sep 26 closing price
Capitalization
10.36B
51 days until earnings call
Interact to see
Advertisement

ABUS vs ROIV

Header iconABUS vs ROIV Comparison
Open Charts ABUS vs ROIVBanner chart's image
Arbutus Biopharma
Price$4.41
Change+$0.09 (+2.08%)
Volume$10.72K
Capitalization845.39M
Roivant Sciences
Price$15.17
Change+$0.21 (+1.40%)
Volume$6.57M
Capitalization10.36B
ABUS vs ROIV Comparison Chart in %
Loading...
ABUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABUS vs. ROIV commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABUS is a Buy and ROIV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ABUS: $4.41 vs. ROIV: $15.17)
Brand notoriety: ABUS and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABUS: 55% vs. ROIV: 101%
Market capitalization -- ABUS: $845.39M vs. ROIV: $10.36B
ABUS [@Biotechnology] is valued at $845.39M. ROIV’s [@Biotechnology] market capitalization is $10.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABUS’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • ABUS’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than ABUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABUS’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 2 bullish TA indicator(s).

  • ABUS’s TA Score: 4 bullish, 5 bearish.
  • ROIV’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ABUS is a better buy in the short-term than ROIV.

Price Growth

ABUS (@Biotechnology) experienced а +3.76% price change this week, while ROIV (@Biotechnology) price change was +0.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ABUS is expected to report earnings on Nov 05, 2025.

ROIV is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($10.4B) has a higher market cap than ABUS($845M). ABUS YTD gains are higher at: 34.862 vs. ROIV (28.233). ABUS has higher annual earnings (EBITDA): -53.13M vs. ROIV (-1.18B). ROIV has more cash in the bank: 4.5B vs. ABUS (98.1M). ABUS has less debt than ROIV: ABUS (1.09M) vs ROIV (99.7M). ROIV has higher revenues than ABUS: ROIV (23.2M) vs ABUS (15.4M).
ABUSROIVABUS / ROIV
Capitalization845M10.4B8%
EBITDA-53.13M-1.18B5%
Gain YTD34.86228.233123%
P/E RatioN/A1.97-
Revenue15.4M23.2M66%
Total Cash98.1M4.5B2%
Total Debt1.09M99.7M1%
FUNDAMENTALS RATINGS
ABUS: Fundamental Ratings
ABUS
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABUSROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 10 days ago
71%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 3 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ABUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGOIX20.75N/A
N/A
Allspring Large Cap Core Inst
VSMCX11.01N/A
N/A
Invesco Small Cap Value C
CVLEX15.53N/A
N/A
Cullen Value Retail
NWHQX35.95N/A
N/A
Nationwide Bailard Tech & Sci M
NSRKX25.94N/A
N/A
Northern World Selection Index K

ABUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABUS
1D Price
Change %
ABUS100%
+2.08%
IDYA - ABUS
47%
Loosely correlated
+4.52%
BMRN - ABUS
43%
Loosely correlated
+2.32%
ROIV - ABUS
42%
Loosely correlated
+1.47%
TERN - ABUS
41%
Loosely correlated
+2.69%
IMVT - ABUS
40%
Loosely correlated
+3.51%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.40%
IMVT - ROIV
59%
Loosely correlated
+3.57%
ACLX - ROIV
52%
Loosely correlated
+1.72%
NUVL - ROIV
52%
Loosely correlated
+4.99%
CRNX - ROIV
52%
Loosely correlated
+27.92%
XENE - ROIV
51%
Loosely correlated
+4.00%
More